Portal de Periódicos da CAPES

Facial Resurfacing for Nonmelanoma Skin Cancer Prophylaxis

2006; American Medical Association; Volume: 142; Issue: 8 Linguagem: Inglês

10.1001/archderm.142.8.976

1538-3652

Basil M. Hantash, Daniel B. Stewart, Zachary A. Cooper, Wingfield Rehmus, R. Koch, Susan M. Swetter,

Reconstructive Facial Surgery Techniques

Objective To determine the effect of facial skin resurfacing for treatment of actinic keratoses (AKs) and prophylaxis against new primary basal and squamous cell carcinomas in individuals with previous nonmelanoma skin cancer (NMSC) or severe photodamage. Design Randomized, prospective 5-year trial. Setting Dermatology and otolaryngology clinics of a Veterans Affairs hospital. Patients Thirty-four patients with a history of facial or scalp AKs or basal or squamous cell carcinoma were enrolled. Five of 7 eligible patients who declined study-related treatment were used as controls. Twenty-seven patients were randomized to 3 treatment arms; 3 patients were discontinued from the study. Interventions Carbon dioxide laser resurfacing, 30% trichloroacetic acid peel, or 5% fluorouracil cream applied twice daily for 3 weeks. Main Outcome Measures Reduction in the number of AKs was measured 3 months after treatment. The incidence of new NMSC in treated areas was assessed between January 1, 2001, and June 30, 2005. Times from baseline to diagnosis of first skin cancer were compared between the treatment and control groups. Results Treatment with fluorouracil, trichloroacetic acid, or carbon dioxide laser resulted in an 83% to 92% reduction in AKs ( P ≤.03), a lower incidence of NMSC compared with the control group ( P <.001), and a trend toward longer time to development of new skin cancer compared with the control group ( P =.07). However, no significant differences were noted among the treatment groups. Conclusion All 3 modalities demonstrated benefit for AK reduction and skin cancer prophylaxis compared with controls and warrant further study in a larger trial.